Head-to-head · Cost-Efficiency Index
REMEVi vs Welling Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
REMEVi
Cost-first shoppers who want bilingual, LegitScript-certified compounded GLP-1.
Visit REMEViWelling Health
Patients willing to log meals daily in exchange for a lower effective GLP-1 price.
Visit Welling HealthThe verdict
REMEVi takes it, leading the Cost-Efficiency Index 80 to 78. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated. Welling Health still earns a C — Patients willing to log meals daily in exchange for a lower effective GLP-1 price.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs REMEVi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | REMEVi | Welling Health |
|---|---|---|
| Cost-Efficiency Index | 80/100 | 78/100 |
| Semaglutide / mo | $219/mo | $190/mo (all doses, promotional rate, compounded) |
| Tirzepatide / mo | $319/mo | $275/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $2,628 | $2,280 |
| Tirzepatide / yr (modeled) | $3,828 | $3,300 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #33 | #40 |
REMEVi
80/100Where the value is
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
The tradeoffs
- The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
Welling Health
78/100Where the value is
- Flat, dose-independent base pricing with no setup or consultation fees disclosed
- Licensed in all 50 states
- Named pharmacy tier (LegitScript-certified 503A, USP <797>) even though the specific pharmacy isn't named
The tradeoffs
- The eye-catching ~30%-off streak price is not the standing rate — it requires 30 unbroken consecutive days of in-app meal logging and resets if a day is missed, so $190/$275 is the realistic price for most patients most of the time
- Tirzepatide's $275 base rate is on the higher end of compounded competitors in this batch
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.